首页> 外文期刊>The Journal of Urology >Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
【24h】

Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.

机译:病理性Gleason评分7级前列腺癌患者生存的预后因素:原发性Gleason 3级和4级之间的结局差异。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We evaluated differences in clinical and pathological outcomes between Gleason 3 + 4 and 4 + 3 prostate cancer. MATERIALS AND METHODS: The radical prostatectomy whole mounted specimens from 263 men with pathological Gleason 7 tumors were identified. Gleason 3 + 4 and 4 + 3 tumors were compared in regard to pathological variables and outcome. Significance of clinical and pathological data on progression-free survival was analyzed. RESULTS: Of the tumors 34% had a primary Gleason grade of 4, and were more likely than those with primary grade 3 to have seminal vesicle involvement (34% versus 18%, p = 0.006), a higher pathological stage (pT3 55% versus 42%, N+ 13% versus 3%, 0.001), extraprostatic extension (58% versus 38%, 0.001) and higher median preoperative prostate specific antigen (PSA) (13.5 versus 9.0 ng./ml., respectively <0.001). Mean followup plus or minus standard deviation was 6.8 +/- 1.9 years. The overall 10-year crude, cancer specific and progression-free survival rates were 83%, 99% and 58%, respectively. Primary Gleason grade was significantly associated with progression-free (risk ratio 1.6, 95% confidence interval 1.08 to 2.5, p = 0.02) but not crude and cancer-specific survival. Univariately, primary Gleason grade 4 was associated with progression-free survival, as were percent Gleason 4, seminal vesicle invasion, lymph node involvement, pT stage, margin status, DNA ploidy, preoperative PSA, cancer volume and extent of extraprostatic extension. Multivariately, only preoperative PSA (p <0.001), seminal vesicle invasion (<0.001) and DNA ploidy (0.002) were associated with progression-free survival. Primary Gleason grade and percent Gleason 4 were not identified as independently associated with progression-free survival. CONCLUSIONS: In patients with Gleason 7 score prostate cancer primary Gleason grade 3 and 4 cancers are different in pathological parameters and prognosis. However, primary Gleason grade does not provide any additional information than other known prognostic factors, such as preoperative PSA, seminal vesicle invasion and DNA ploidy.
机译:目的:我们评估了格里森3 + 4和4 + 3前列腺癌在临床和病理结果上的差异。材料与方法:从263名患有病理性Gleason 7肿瘤的男性中根治性前列腺切除术整个标本进行了鉴定。比较了格里森3 + 4和4 + 3肿瘤的病理变量和预后。分析了无进展生存期的临床和病理学数据的意义。结果:在这些肿瘤中,有34%的原发性格里森分级为4,比原发性3级的肿瘤更容易发生精囊侵犯(34%比18%,p = 0.006),病理分期更高(pT3 55%相对于42%,N + 13%对3%,0.001),前列腺外延伸(58%对38%,0.001)和术前前列腺特异性抗原(PSA)的中位数更高(分别为13.5和9.0 ng./ml。<0.001)。平均随访正负标准差为6.8 +/- 1.9年。总体10年原油,癌症特异性和无进展生存率分别为83%,99%和58%。最初的Gleason分级与无进展显着相关(风险比1.6,95%置信区间1.08至2.5,p = 0.02),但与原始生存率和癌症特异性生存率无关。单因素地,原发性格里森4级与无进展生存相关,格里森4百分率与精囊侵袭,淋巴结受累,pT分期,切缘状态,DNA倍性,术前PSA,癌变量和前列腺外扩张程度相关。多因素分析,只有术前PSA(p <0.001),精囊侵犯(<0.001)和DNA倍性(0.002)与无进展生存相关。原发性格里森等级和百分格里森4未被确定为与无进展生存独立相关。结论:在格里森评分为7的前列腺癌患者中,原发性格里森3和4级癌症的病理参数和预后不同。但是,除了其他已知的预后因素(如术前PSA,精囊浸润和DNA倍性)外,初级Gleason评分未提供任何其他信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号